Ground Swell Capital’s Enzymotec Ltd ENZY Stock Holding History

Ground Swell Capital’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1K	Buy	+106	New	+$1.14K	﹤0.01%	2288

Other funds holding ENZY

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MACM

March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Ground Swell Capital's ENZY Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Enzymotec Ltd (ENZY) in Q3 2014: 106 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2288 among its holdings.

22 funds tracked by Wall St. Rank hold ENZY as of Q3 2014.

Ground Swell Capital held 106 shares of Enzymotec Ltd worth $1K as of Q3 2014.
Enzymotec Ltd was a new Ground Swell Capital position in Q3 2014.
Enzymotec Ltd made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2288 holding.
22 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.